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Why do we offer palliative care so late to patients with liver disease?  
 
Patients with advanced liver disease carry a high symptom burden and short life expectancy, but 
receive limited supportive and palliative care1. Providing planned day care for large volume 
paracentesis reduced costs, inpatient bed days and probability of dying in hospital after an unplanned 
admission1. These recent findings illustrate how care to people with advanced liver disease can be 
improved with the burden on acute service alleviated by the adoption of day-case models across the 
UK. This point is timely as palliative care provision for this group is poor, often occurring near to the 
patients’ death2. Why is this? It is recognised that prognosis or future care needs are often not 
discussed with liver patients until the very late stages of the disease. Clinicians report that they lack 
the expertise and confidence to initiate these discussions and a limited understanding about what 
palliative care can offer, and believe that patients have negative expectations of palliative care 
referral2. Conversations regarding palliation often introduces family members into the patient and 
clinician relationship, and family members may be resistant to the idea of palliative care2. 
Furthermore, many clinicians find it difficult to identify the point of ‘deterioration’ due to the fluctuating 
disease trajectory of advanced cirrhosis.  
 
Liver clinicians perceive themselves as poor prognosticators, but patients in the last year of life share 
common clinical characteristics warranting referral to palliative care, such as frequent hospital 
admission and heavy symptom burden2. Prognostic tools now exist which help to identify when 
referral to specialist palliative care may be beneficial3. Perceived barriers about the appropriateness 
of palliative care in patients with advanced liver disease can be broken down if liver and palliative care 
clinicians work jointly at an early phase4. Increasingly, there is collaborative working in joint clinics and 
in developing shared care pathways to facilitate patient-centred and cost–effective care. Although 
these interventions are at a developmental stage, initial results show their potential in improving 
patient outcomes and promoting open end of life discussions5. They may be instrumental in mutually 
educating liver clinicians as to what palliative care can offer, and palliative care clinicians in aspects of 
advanced liver disease management2,. Further work is needed to address the cost-effectiveness of 
these interventions, in addition to supporting clinicians in their communication with patients, improving 
understanding of patients’ care needs and improving patients’ understanding of their disease.  
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